DOWNLOAD OUR
BROCHURE

Innovation

Driving Science Into Breakthrough Solutions.

At NGL, innovation is driven by a dedicated R&D team focused on expanding the product portfolio and boosting operational efficiency.

With deep expertise in complex multi-step organic synthesis, the team consistently adds high-value generic APIs and intermediates to the pipeline. R&D works closely with Quality Assurance (QA), Quality Control (QC), and Regulatory Affairs (RA) to ensure seamless compliance and continuous innovation.

Strategic collaborations with academic institutions and research organizations further elevate NGL’s capabilities, enabling the adoption of cutting-edge science and reinforcing its leadership in veterinary medicine. This integrated approach ensures NGL remains agile, forward-looking, and committed to breakthrough pharmaceutical solutions.

46

APIs

4

Intermediates

43

Veterinary APIs

3

Human APIs

Pillars of R&D Excellence

Active Pharmaceutical Ingredients (APIs)

Driving innovation in high-quality APIs for human and veterinary use, with enhanced purity, stability, and scalable manufacturing processes.

Specialty Chemicals

Application-focused specialty chemicals built for precision, consistency, and seamless integration into regulated environments.

Process Development

We excel at complex multi-step synthesis for APIs and intermediates. An active research lab, a kilo lab facility, and a versatile pilot plant, combined with modern analytical services, enable us to deliver an integrated value proposition to global customers.

Through academic collaborations and advanced technologies, we transform literature into scalable, commercially viable processes.

Custom Synthesis

Our synthetic chemistry expertise, combined with problem-solving skills, enables safe and efficient commercialization of complex molecules to meet your custom manufacturing needs.

With advanced labs, full reaction capabilities, and integrated analytical services, we deliver high-purity compounds cost-effectively through scale-up, process development, and validation.

Reaction Capabilities

Our Pilot Plants

⁠We operate modern pilot plants designed for efficient scale-up and development of new products and processes. With advanced infrastructure and versatile capabilities, we ensure seamless transition from laboratory innovation to commercial production.

2,000 sq. ft.

Plant Area

50 L × 5

Glass Reactors

4

Dedicated Pilot Plants

9.5kL

Total Pilot Capacity

GLR, SSR & Hastelloy

Versatile MOC

100L - 630L

Scalable Units

200 kg/hr

Precision Milling

Multi-Facility

Integrated R&D